Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1977 4
1978 4
1979 1
1980 3
1981 4
1982 8
1983 11
1984 1
1985 10
1986 7
1987 7
1988 3
1989 4
1990 2
1991 1
1992 5
1993 7
1994 5
1995 3
1996 1
1997 7
1998 5
1999 3
2000 4
2001 8
2002 1
2003 9
2004 4
2005 7
2006 10
2007 5
2008 4
2009 6
2010 6
2011 7
2012 12
2013 10
2014 8
2015 7
2016 5
2017 4
2018 1
2019 4
2020 5
2021 8
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiency.
Thouenon R, Chentout L, Moreno-Corona N, Poggi L, Lombardi EP, Hoareau B, Schmitt Y, Lagresle-Peyrou C, Bustamante J, André I, Cavazzana M, Durandy A, Casanova JL, Galicier L, Fadlallah J, Fischer A, Kracker S. Thouenon R, et al. Among authors: durandy a. J Exp Med. 2023 Jun 5;220(6):e20221292. doi: 10.1084/jem.20221292. Epub 2023 Mar 14. J Exp Med. 2023. PMID: 36917008 Free PMC article.
Primary antibody deficiencies.
Durandy A, Kracker S, Fischer A. Durandy A, et al. Nat Rev Immunol. 2013 Jul;13(7):519-33. doi: 10.1038/nri3466. Epub 2013 Jun 14. Nat Rev Immunol. 2013. PMID: 23765059 Review.
Hyper-IgM syndrome.
Di Santo JP, de Saint Basile G, Durandy A, Fischer A. Di Santo JP, et al. Among authors: durandy a. Res Immunol. 1994 Mar-Apr;145(3):205-9; discussion 244-9. doi: 10.1016/s0923-2494(94)80185-1. Res Immunol. 1994. PMID: 7991944 Review. No abstract available.
Hyper-IgM syndromes.
Durandy A, Peron S, Fischer A. Durandy A, et al. Curr Opin Rheumatol. 2006 Jul;18(4):369-76. doi: 10.1097/01.bor.0000231905.12172.b5. Curr Opin Rheumatol. 2006. PMID: 16763457 Review.
Activated PI3Kinase Delta Syndrome-A Multifaceted Disease.
Thouenon R, Moreno-Corona N, Poggi L, Durandy A, Kracker S. Thouenon R, et al. Among authors: durandy a. Front Pediatr. 2021 Jun 25;9:652405. doi: 10.3389/fped.2021.652405. eCollection 2021. Front Pediatr. 2021. PMID: 34249806 Free PMC article. Review.
Recombinant soluble trimeric CD40 ligand is biologically active.
Mazzei GJ, Edgerton MD, Losberger C, Lecoanet-Henchoz S, Graber P, Durandy A, Gauchat JF, Bernard A, Allet B, Bonnefoy JY. Mazzei GJ, et al. Among authors: durandy a. J Biol Chem. 1995 Mar 31;270(13):7025-8. doi: 10.1074/jbc.270.13.7025. J Biol Chem. 1995. PMID: 7706236 Free article.
Defects of class-switch recombination.
Notarangelo LD, Lanzi G, Peron S, Durandy A. Notarangelo LD, et al. Among authors: durandy a. J Allergy Clin Immunol. 2006 Apr;117(4):855-64. doi: 10.1016/j.jaci.2006.01.043. J Allergy Clin Immunol. 2006. PMID: 16630945 Review.
Immunoglobulin class switch recombination deficiencies.
Kracker S, Gardes P, Mazerolles F, Durandy A. Kracker S, et al. Among authors: durandy a. Clin Immunol. 2010 May;135(2):193-203. doi: 10.1016/j.clim.2010.01.012. Epub 2010 Feb 18. Clin Immunol. 2010. PMID: 20167540 Review.
236 results